Immuno-Oncology Market

The immuno-oncology market encompasses advanced therapeutic approaches that use the body's own immune system to recognize and fight cancer cells. The primary customers are healthcare systems, biopharmaceutical companies, and research institutions focused on oncology. Key growth drivers include the rapid adoption of combination immunotherapies that enhance efficacy and the increasing focus on biomarker-driven strategies for developing personalized, targeted cancer treatments.